Healthcare provider profile · identity verified

Timothy Jay Horrocks

Family Practice · WOODLAND, WA · NPI 1770018087

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	471	133
Amlodipine Besylate	Amlodipine Besylate	258	72
Levothyroxine Sodium	Levothyroxine Sodium	212	52
Losartan Potassium	Losartan Potassium	196	61
Lisinopril	Lisinopril	194	56
Rosuvastatin Calcium	Rosuvastatin Calcium	187	49
Omeprazole	Omeprazole	173	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	166	47
Oxycodone Hcl	Oxycodone Hcl	143	33
Furosemide	Furosemide	133	36
Gabapentin	Gabapentin	133	54
Metoprolol Succinate	Metoprolol Succinate	128	32
Tamsulosin Hcl	Tamsulosin Hcl	119	39
Albuterol Sulfate Hfa	Albuterol Sulfate	117	40
Metformin Hcl	Metformin Hcl	107	35
Pantoprazole Sodium	Pantoprazole Sodium	88	25
Tramadol Hcl	Tramadol Hcl	86	22
Metformin Hcl Er	Metformin Hcl	84	30
Allopurinol	Allopurinol	79	23
Trazodone Hcl	Trazodone Hcl	79	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	32
Metoprolol Tartrate	Metoprolol Tartrate	75	22
Pregabalin	Pregabalin	74	19
Eliquis	Apixaban	73	20
Hydrochlorothiazide	Hydrochlorothiazide	69	23
Meloxicam	Meloxicam	68	28
Fluoxetine Hcl	Fluoxetine Hcl	67	16
Potassium Chloride	Potassium Chloride	66	22
Simvastatin	Simvastatin	65	16
Hydroxyzine Hcl	Hydroxyzine Hcl	63	14
Montelukast Sodium	Montelukast Sodium	58	14
Jardiance	Empagliflozin	55	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	14
Triamcinolone Acetonide	Triamcinolone Acetonide	55	24
Tizanidine Hcl	Tizanidine Hcl	54	22
Pravastatin Sodium	Pravastatin Sodium	53	18
Citalopram Hbr	Citalopram Hydrobromide	52	suppressed
Sertraline Hcl	Sertraline Hcl	51	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	13
Fluticasone Propionate	Fluticasone Propionate	47	22
Benazepril Hcl	Benazepril Hcl	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	11
Prednisone	Prednisone	42	24
Clopidogrel	Clopidogrel Bisulfate	41	15
Donepezil Hcl	Donepezil Hcl	41	12
Famotidine	Famotidine	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Atenolol	Atenolol	39	13
Lorazepam	Lorazepam	39	17
Bupropion Xl	Bupropion Hcl	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	18
Escitalopram Oxalate	Escitalopram Oxalate	35	11
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Ozempic	Semaglutide	34	11
Ibuprofen	Ibuprofen	33	suppressed
Rybelsus	Semaglutide	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Glipizide Er	Glipizide	30	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Lovastatin	Lovastatin	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	13
Baclofen	Baclofen	28	suppressed
Carvedilol	Carvedilol	28	suppressed
Methocarbamol	Methocarbamol	28	12
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Colchicine	Colchicine	20	suppressed
Acyclovir	Acyclovir	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Valsartan	Valsartan	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Zaleplon	Zaleplon	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Ezetimibe	Ezetimibe	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	11
Lansoprazole	Lansoprazole	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Glipizide	Glipizide	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Testosterone	Testosterone	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error